Transcriptional profiling and network pharmacology analysis identify the potential biomarkers from Chinese herbal formula Huosu Yangwei Formula treated gastric cancer in vivo

2021 ◽  
Vol 19 (12) ◽  
pp. 944-953
Author(s):  
Sheng-Quan FANG ◽  
Yue-Han LIU ◽  
Kun-Peng ZHAO ◽  
Hui-Xing ZHANG ◽  
Hong-Wei WANG ◽  
...  
2020 ◽  
Vol 72 (7) ◽  
pp. 979-989
Author(s):  
Sheng‐Quan Fang ◽  
Jian Huang ◽  
Feng Zhang ◽  
Hong‐Mei Ni ◽  
Qi‐Long Chen ◽  
...  

Viruses ◽  
2018 ◽  
Vol 10 (3) ◽  
pp. 117 ◽  
Author(s):  
Qinhai Ma ◽  
Qingtian Yu ◽  
Xuefeng Xing ◽  
Sinian Liu ◽  
Chunyu Shi ◽  
...  

2013 ◽  
Vol 150 (2) ◽  
pp. 521-528 ◽  
Author(s):  
Qiang Liu ◽  
Li Lu ◽  
Moli Hua ◽  
Yu Xu ◽  
Hairong Xiong ◽  
...  

Author(s):  
Deng-hai Zhang ◽  
Xue Zhang ◽  
Bin Peng ◽  
Sheng-qiong Deng ◽  
Yu-fang Wang ◽  
...  

Abstract Chinese herbal formulas, notably the lung-cleaning and toxicity-excluding (LCTE) soup has played an important role in treating an ongoing and life-threating worldwide pandemic, COVID-19 (caused by SARS-CoV-2). Applying LCTE outside of China may be difficult for medical society to approach due to the unfamiliar rationale behind its application in terms of Traditional Chinese Medicine. To overcome this barrier, we illuminate the chemical and biological mechanisms behind LCTE’s effects, by exploring the chemical compounds contained in LCTE ingredients, the proteins targeted by these compounds as well as undertaking the network pharmacology analysis. The results disclosed that LCTE contains compounds with the potential to directly inhibit SARS-CoV-2 and inflammation, and that the compounds targeted proteins significantly related to the main symptoms seen in COVID-19. The general effect of LCTE was to affect the pathways involved in viral and other microbe infection, inflammation/cytokine response, and lung diseases. Our work provided chemical biological explanations for using LCTE to treat COVID-19.


2017 ◽  
Vol 2017 ◽  
pp. 1-12 ◽  
Author(s):  
Hou-Cai Huang ◽  
Chun-Fei Wang ◽  
Jun-Fei Gu ◽  
Juan Chen ◽  
Xue-Feng Hou ◽  
...  

Goutengsan, a Chinese herbal formula, potential protection on Alzheimer’s disease (AD) has been less reported. In current study, we investigated the protection of Goutengsan on Aβ1–42-induced pheochromocytoma-derived cells (PC12). Furthermore, the components from Goutengsan in rat plasma were identified by microdialysis (MD) forin vivosampling. Meanwhile, the protection of components identified was also verified. At last, we found that Goutengsan has a potential protective effect on Aβ1–42-induced PC12 cells via reducing cells damage and increasing cells vitality as well as six components (pachymic acid, liquiritin, rhynchophylline, isorhynchophylline, corynoxeine, and isocorynoxeine) which may be effective components. This study helps to understand the treatment of Goutengsan for AD and would facilitate the clinical and further studies for this formula.


2011 ◽  
Vol 140 (5) ◽  
pp. S-515
Author(s):  
Zhonghan Yang ◽  
Viktoriya Grinchuk ◽  
Terez Shea-Donohue ◽  
Chun-Tao Che ◽  
Lixing Lao ◽  
...  

2012 ◽  
Vol 29 (3) ◽  
pp. 1080-1086 ◽  
Author(s):  
ZHIYUN CAO ◽  
WEI LIN ◽  
ZHENGRONG HUANG ◽  
XUZHENG CHEN ◽  
JINYAN ZHAO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document